Chimeric CD4/CD44 molecules associate with CD44 via the transmembrane region and reduce hyaluronan binding in T cell lines

European Journal of Immunology

Volumn 28, Issue 6, 1998, Pages 1745-1754

  Li, Ruihong ^a   Walker, John R ^a,b   Johnson, Pauline ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

CD44; Hyaluronan binding; Transmembrane domain

Indexed keywords

CD4 ANTIGEN; HERMES ANTIGEN; HYALURONIC ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA; T LYMPHOCYTE;

3T3 CELLS; ANIMALS; ANTIGENS, CD4; ANTIGENS, CD44; BINDING SITES; CELL MEMBRANE; HUMANS; HYALURONIC ACID; MICE; PRECIPITIN TESTS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031843289     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199806)28:06<1745::AID-IMMU1745>3.0.CO;2-5     Document Type: Article

References (56)

1. Lesley, J., Hyman, R. and Kincade, P. W., CD44 and its interaction with the extracellular matrix. Adv. Immunol. 1993. 54: 271-335.
2. Springer, T. A., Adhesion receptors of the immune system. Nature 1990. 346: 425-434.
3. Springer, T. A., Traffic signals for lymphocyte recirculation and leukocyte emigration. Cell 1994. 76: 301-314.
4. Tedder, T. F., Steeber, D. A., Chen, A. and Engel, P., The selectins: vascular adhesion molecules. FASEB J. 1995. 9: 866-873.
5. Camp, R. L., Scheynius, A., Johansson, C. and Pure, E., CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J. Exp. Med. 1993. 178: 497-507.
6. DeGrendele, H. C., Estess, P., Picker, L. J. and Siegelman, M. H., CD44 and its ligand hyaluronate mediate rolling under physiologic flow - a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 1996. 183: 1119-1130.
7. Clark, R. A., Alon, R. and Springer, T. A., CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J. Cell Biol. 1996. 134: 1075-1087.
8. Lesley, J., Schulte, R. and Hyman, R., Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp. Cell Res. 1990. 187: 224-233.
9. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B. and Seed, B., CD44 is the principal cell surface receptor for hyaluronate. Cell 1990. 61: 1303-1313.
10. Miyake, K., Underhill, C. B., Lesley, J. and Kincade, P. W., Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 1990. 172: 69-75.
11. Culty, M., Miyake, K., Kincade, P. W., Silorski, E., Butcher, E. C. and Underhill, C., The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J. Cell Biol. 1990. 111: 2765-2774.
12. Miyake, K., Medina, K. L., Hayashi, S.-I., Ono, S., Hamaoka, T. and Kincade, P. W., Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med. 1990. 171: 477-488.
13. Murakami, S., Miyake, K., June, C. H., Kincade, P. W. and Hodes, R. J., IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol. 1990. 145: 3618-3627.
14. Lesley, J., Howes, N., Perschl, A. and Hyman, R., Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med. 1994. 180: 383-387.
15. Herrlich, P., Zoller, M., Pals, S. T. and Ponta, H., CD44 Splice Variants - Metastases Meet Lymphocytes. Immunol. Today 1993. 14: 395-399.
16. Cooper, D. L. and Dougherty, G. J., To metastasize or not - selection of CD44 splice sites. Nature Med. 1995. 1: 635-637.
17. Lesley, J. and Hyman, R., CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur. J. Immunol. 1992. 22: 2719-2723.
18. Stamenkovic, I., Aruffo, A., Amiot, M. and Seed, B., The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 1991. 10: 343-348.
19. Katoh, S., Zheng, Z., Oritani, K., Shimozato, T. and Kincade, P. W., Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 1995. 182: 419-429.
20. Lesley, J., English, N., Perschl, A., Gregoroff, J. and Hyman, R., Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 1995. 182: 431-437.
21. van der Voort, R., Manten-Horst, E., Smit, L., Ostermann, E., van den Berg, F. and Pals, S. T., Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type. Biochem. Biophys. Res. Commun. 1995. 214: 137-144.
22. Bennett, K. L., Modrell, B., Greenfield, B., Bartolazzi, A., Stamenkovic, I., Peach, R., Jackson, D. G., Spring, F. and Aruffo, A., Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol. 1995. 131: 1623-1633.
23. Bartolazzi, A., Nocks, A., Aruffo, A., Spring, F. and Stamenkovic, I., Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell Biol. 1996. 132: 1199-1208.
24. Takahashi, K., Stamenkovic, I., Cutler, M., Dasgupta, A. and Tanabe, K. K., Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J. Biol. Chem. 1996. 271: 9490-9496.
25. Dasgupta, A., Takahashi, K., Cutler, M. and Tanabe, K. K., O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells. Biochem. Biophys. Res. Commun. 1996. 227: 110-117.
26. Perschl, A., Lesley, J., English, N., Trowbridge, I. and Hyman, R., Role of CD44 cytoplasmic domain in hyaluronan binding. Eur. J. Immunol. 1995. 25: 495-501.
27. Sleeman, J., Rudy, W., Hofmann, M., Moll, J., Herrlich, P. and Ponta, H., Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J. Cell Biol. 1996. 135: 1139-1150.
28. Lesley, J., He, Q., Miyake, K., Hamann, A., Hyman, R. and Kincade, P. W., Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J. Exp. Med. 1992. 175: 257-266.
29. Pure, E., Camp, R. L., Peritt, D., Panettieri, R. A. J., Lazaar, A. L. and Nayak, S., Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med. 1995. 181: 55-62.
30. Liu, D. and Sy, M. S., A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid. J. Exp. Med. 1996. 183: 1987-1994.
31. Liu, D. and Sy, M. S., Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain. J. Immunol. 1997. 159: 2702-2711.
32. Lesley, J., Kincade, P. W. and Hyman, R., Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur. J. Immunol. 1993. 23: 1902-1909.
33. Beyers, A. D., Spruyt, L. L. and Williams, A. F., Molecular associations between the T lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. Proc. Natl. Acad. Sci. USA 1992. 89: 2945-2949.
34. Schraven, B., Wild, M., Kirchgessner, H., Siebert, B., Wallich, R., Henning, S., Samstag, Y. and Meuer, S. C., Alterations of CD2 association with T cell receptor signaling molecules in "CD2 unresponsive" human T lymphocytes. Eur. J. Immunol. 1993. 23: 119-123.
35. Hutchcroft, J. E. and Bierer, B. E., Activation-dependent phosphorylation of the T-lymphocyte surface receptor CD28 and associated proteins. Proc. Natl. Acad. Sci. USA 1994. 91: 3260-3264.
36. Berditchevski, F., Bazzoni, G. and Hemler, M., Specific association of CD63 with the VLA-3 and VLA-6 integrins. J. Biol. Chem. 1995. 270: 17784-17790.
37. Cerny, J., Stockinger, H. and Horejsi, V., Noncovalent associations of T lymphocyte surface proteins. Eur. J. Immunol. 1996. 26: 2335-2343.
38. Kitamura, K., Maiti, A., Ng, D. H. W., Johnson, P., Maizel, A. L. and Takeda, A., Characterization of the interaction between CD45 and CD45-AP. J. Biol. Chem. 1995. 270: 21151-21157.
39. Cahir McFarland, E. D. and Thomas, M. L., CD45 protein-tyrosine phosphatase associates with the WW domain-containing protein, CD45AP, through the transmembrane region. J. Biol. Chem. 1995. 270: 28103-28107.
40. Bruyns, E., Hendricks-Taylor, L. R., Meuer, S., Koretzky, G. A. and Schraven, B., Identification of the site of interaction between lymphocyte phosphatase-associated phosphoprotein (LPAP) and CD45. J. Biol. Chem. 1995. 270: 31372-31376.
41. Cahir McFarland, E. D., Pingel, J. and Thomas, M. L., Definition of amino acids sufficient for plasma membrane association of CD45 and CD45-associated protein. Biochemistry 1997. 36: 7169-7175.
42. Furthmayr, H. and Marchesi, V. T., Subunit structure of human erythrocyte glycophorin A. Biochemistry 1976. 15: 1137-1144.
43. Lemmon, M. A., Flanagan, J. M., Hunt, J. F., Adair, B. D., Bormann, B.-J., Dempsey, C. E. and Engelman, D. M., Glycophorin A dimerization is driven by specific interaction between transmembrane a-helices. J. Biol. Chem. 1992. 267: 7683-7689.
44. MacKenzie, K. R., Prestegard, J. H. and Engelman, D. M., A transmembrane helix dimer: structure and implications. Science 1997. 276: 131-133.
45. Detmers, P. A., Wright, S. D., Olsen, E., Kimball, B. and Cohn, Z. A., Aggregation of complement receptors on human neutrophils in the absence of ligand. J. Cell Biol. 1987. 105: 1137-1145.
46. Dustin, M. L., Olive, D. and Springer, T. A., Correlation of CD2 binding and functional properties of multimeric and monomeric lymphocyte function-associated antigen 3. J. Exp. Med. 1989. 169: 503-517.
47. Reilly, P. L., Woska, J. R. J., Jeanfavre, D. D., McNally, E., Rothlein, R. and Bormann, B.-J., The native structure of Intercellular Adhesion Molecule-1 (ICAM-1) is a dimer. J. Immunol. 1995. 155: 529-532.
48. Miller, J., Knorr, R., Ferrone, M., Houdei, R., Carron, C. P. and Dustin, M. L., Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J. Exp. Med. 1995. 182: 1231-1241.
49. Hyman, R. and Stallings, V., Complementation patterns of Thy-1 variants and evidence that antigen loss variants "pre-exist" in the parental population. J. Natl. Cancer Inst. 1974. 52: 429-437.
50. Wegener, A.-M., K., Letourneur, F., Hoeveler, A., Brocker, T., Luton, F. and Malissen, B., The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell 1992. 68: 83-95.
51. Falo, L. D. J., Benacerraf, B. and Rock, K. L., Phospholipase treatment of accessory cells that have been exposed to antigen selectively inhibits antigen-specific la-restricted, but not allospecific, stimulation of T lymphocytes. Proc. Natl. Acad. Sci. USA 1986. 83: 6994-6997.
52. Trowbridge, I. S., Lesley, J., Schulte, R., Hyman, R. and Trotter, J., Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics 1982. 15: 299-312.
53. McCallus, D. E., Ugen, K. E., Sato, A. L., Williams, W. V. and Weiner, D. B., Construction of a recombinant bacterial human CD4 expression system producing a bioactive CD4 molecule. Viral Immunol. 1992. 5: 163-172.
54. Maddon, P., Littman, D., Godfrey, M., Maddon, D., Chess, L. and Axel, R., The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell 1985. 42: 93-104.
55. Karasuyama, H. and Melchers, F., Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 1988. 18: 97-104.
56. De Belder, A. N. and Ove Wik, K., Preparation and properties of fluorescein-labeled hyaluronate. Carbohydrate Res. 1975. 44: 251-257.